The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Marinus Pharma
MRNS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.43
0.01
1.06%
At Close: -
$1.45
0.02
1.40%
After Hours: 7:25 PM EDT
15 minutes delayed
Get Report
Comment
Marinus Pharma (MRNS) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Marinus Pharma (NASDAQ:MRNS) Stock
Marinus Pharma Stock (NASDAQ: MRNS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 18, 2024
China National Medical Products Administratio...
Benzinga Newsdesk
Tuesday, June 18, 2024
Truist Securities Maintains Buy on Marinus Ph...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Marinus...
Benzinga Newsdesk
Monday, June 17, 2024
Marinus Pharmaceuticals Shares Mixed Results From IV Formulated Ganaxolone In Pretreated Seizure Patients
Vandana Singh
Marinus Pharmaceuticals Announced Topline Res...
Benzinga Newsdesk
Thursday, June 13, 2024
Avidity Up 33% on Rare Muscle Disease Study Results
Zacks
Ultragenyx Posts New Data From Bone Disease Study
Zacks
Friday, May 24, 2024
Candel Reports Upbeat Data From Lung Cancer Study
Zacks
Friday, May 17, 2024
Marinus Pharmaceuticals Wraps Phase 3 Trial E...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Reiterates Buy on Marinus...
Benzinga Newsdesk
Wednesday, May 08, 2024
Marinus Pharmaceuticals Expects That Cash, Ca...
Benzinga Newsdesk
Marinus Pharmaceuticals Has Increased 2024 Pr...
Benzinga Newsdesk
Marinus Pharma Q1 2024 GAAP EPS $(0.68) Misse...
Benzinga Newsdesk
Tuesday, May 07, 2024
Unveiling 10 Analyst Insights On Marinus Pharma
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Marinus ...
Benzinga Newsdesk
Monday, April 29, 2024
How Is The Market Feeling About Marinus Pharma?
Benzinga Insights
Wednesday, April 17, 2024
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
RBC Capital Downgrades Marinus Pharma to Sect...
Benzinga Newsdesk
Tuesday, April 16, 2024
Analysts Question Commercial Viability of Marinus' IV Ganaxolone After Interim Analysis Miss
Vandana Singh
The Latest Analyst Ratings For Marinus Pharma
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Marinus...
Benzinga Newsdesk
Monday, April 15, 2024
RBC Capital Downgrades Marinus Pharma to Sect...
Benzinga Newsdesk
S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
Avi Kapoor
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Crude Oil Down 1%; Charles Schwab Sales Top Estimates
Avi Kapoor
Why Did Epilepsy/Seizure Focused-Marinus Pharmaceuticals Stock Hit 52-Week Low On Monday?
Vandana Singh
Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings
Avi Kapoor
Marinus Pharmaceuticals shares are trading lo...
Benzinga Newsdesk
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Marinus Pharma Reported Prelim ZTALMY (Ganaxo...
Benzinga Newsdesk
Trading Halt: Halt status updated at 7:25:00 ...
Benzinga Newsdesk
Marinus Pharma to Continue Phase 3 RAISE Tria...
Benzinga Newsdesk
Trading Halt: Halted at 6:55:00 a.m. ET - Tra...
Benzinga Newsdesk
Wednesday, April 10, 2024
Cantor Fitzgerald Reiterates Overweight on Ma...
Benzinga Newsdesk
Wednesday, March 27, 2024
Marinus Pharmaceuticals Comments On Ovid Ther...
Benzinga Newsdesk
Tuesday, March 26, 2024
Peeling Back The Layers: Exploring Marinus Pharma Through Analyst Insights
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Marinus...
Benzinga Newsdesk
Thursday, March 07, 2024
The Medicines And Healthcare Products Regulat...
Benzinga Newsdesk
Oppenheimer Maintains Perform on Marinus Phar...
Benzinga Newsdesk
Wednesday, March 06, 2024
RBC Capital Reiterates Outperform on Marinus ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Marinus...
Benzinga Newsdesk
Tuesday, March 05, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Leverage Shares -3x Short Moderna (MRNA) ETP Securities: Q4 Earnings Insights
Benzinga Insights
Marinus Pharma Q4 2023 GAAP EPS $(0.740) Miss...
Benzinga Newsdesk
Earnings Scheduled For March 5, 2024
Benzinga Insights
Monday, March 04, 2024
Marinus Pharma's Earnings Outlook
Benzinga Insights
Thursday, February 08, 2024
Marinus Pharmaceuticals 13G Filing Shows Jenn...
Benzinga Newsdesk
Thursday, January 04, 2024
Marinus Pharmaceuticals Projects Fy24 U.S. Zt...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch